Protein formulation

Details Protein formulation Protein formulation

2005-12-12

2008-09-09

Carlson, Karen Cochrane (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S300000, C530S350000

Reexamination Certificate

active

07423013

ABSTRACT:
A low-concentration formulation of an active enamel substance, such as an enamel matrix, enamel matrix derivative and/or an enamel matrix protein, is intended to be used as a therapeutic, as a prophylactic and/or as a cosmetic agent. The active enamel substance is incorporated into a polymeric matrix, which is either suitable for cellular in-growth, or is cell-occlusive, so that it is released by degradation of the polymeric matrix, by enzymatic action and/or by diffusion. A new pharmaceutical and/or cosmetic formulation of an active enamel substance is provided at a lower total concentration within the formulation, wherein a spatial and/or selective regulation of release of said active enamel substance permits a greater percentage of the active enamel substance to be released at the time of appropriate cellular activity.

REFERENCES:
patent: 4672032 (1987-06-01), Slavkin et al.
patent: 5874500 (1999-02-01), Rhee et al.
patent: 5997301 (1999-12-01), Linden
patent: 6503539 (2003-01-01), Gestrelius et al.
patent: 2003/0166833 (2003-09-01), Lutolf et al.
patent: 2003/0187232 (2003-10-01), Hubbell et al.
patent: 0 337 967 (1989-10-01), None
patent: 0 263 086 (1991-12-01), None
patent: 1 059 934 (2000-12-01), None
patent: 1 153 610 (2001-11-01), None
patent: WO 00/06734 (2000-02-01), None
patent: WO 00/44808 (2000-08-01), None
patent: WO 00/53196 (2000-09-01), None
patent: WO 01/97834 (2001-12-01), None
patent: WO 02/080994 (2002-10-01), None
patent: WO 03/052091 (2003-06-01), None
Gestrelius et al. 1997; Formulation of enamel matrix derivative for surface coating; kinetics and cell colonization. J. Clin. Periodontol. (24(9 pt 2): 678-684.
Besson, et al., “Synthetic Peptide Substrates for a Conductimetric Assay ofPseudomonas aeruginosaElastase”, Analytical Biochemistry, vol. 237, No. 232, pp. 216-223, Academic Press, Inc., 1996.
Coombs, et al., “Directing Sequence-specific Proteolysis to New Targets”, The Journal of Biological Chemistry, Vo. 273, No. 8, pp. 4323-4328, The American Society for Biochemistry and Molecular Biology, Inc., 1998.
Gestrelius, et al., “Emdogain—periodontal regeneration based on biomimicry”, Clin Oral Invest, vol. 4, pp. 120-125, Springer-Veriag, 2000.
Hammarström, et al., “Enamel matrix, cementum development and regeneration”, J of Clin Periodontol, vol. 24, pp. 658-668, J. Clin Periodontol, 1997.
Hata, et al., “Binding of Lipoprotein Lipase to Heparin”, The Journal of Biological Chemistry, vol. 268, No. 12, pp. 8447-8457, 1993.
Haugen, et al., “Central and Peripheral Neurite Outgrowth Differs in Preference for Heparin-Binding versus Integrin-Binding Sequences”, The Journal of Neuroscience, vol. 12, No. 6, pp. 2034-2042, Soceity for Neuroscience, 1992.
Hern, et al., “Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing”, J Biomed Mater Res, vol. 39, pp. 266-276, John Wiley & Sons, Inc., 1998.
Kallapur, et al., “The Neural Cell Adhesion Molecule (NCAM) Heparin Binding Domain Binds to Cell Surface Heparan Sulfate Proteoglycans”, Journal of Neuroscience Research, vol. 33, pp. 538-548, Wiley-Liss, Inc., 1992.
Lyngstadaas, et al., “Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative”, J Clin Periodontol, vol. 28, pp. 181-188, J. Clin Periodontol, 2001.
Netzel-Arnett, et al., “Sequence Specificities of Human Fibroblast and Neutrophil Collagenases”, The Journal of Biological Chemistry, vol. 266, No. 11, pp. 6747-6755, The American Society for Biochemistry and Molecular Biology, Inc., 1991.
Schense, et al., “Cross-Linking Exogenous Bifunctional Peptides into Fibrin Gels with Factor XIIIa”, Bioconjugate Chem., vol. 10, pp. 75-81, American Chemical Society, 1999.
Sierra, David H., “Fibrin Sealant Adhesive Systems: A Review of Their Chemistry, Material Properties and Clinical Applications”, Journal of Biomaterials Applications, vol. 7, pp. 309-352, Technomic Publishing Co., Inc., 1993.
Smith, et al., “Rapid Identification of Highly Active and Selective Substrates for Stromelysin and Matrilysin Using Bacteriophage Peptide Display Libraries”, The Journal of Biological Chemistry, vol. 270, No. 12, pp. 6440-6449, The American Society for Biochemistry and Molecular Biology, Inc., 1995.
Takagi, et al., “Amino Acid Sequence Studies on the α Chain of Human Fibrinogen. Location of Four Plasmin Attack Points and a Covalent Cross-Linking Site”, Biochemistry, vol. 14, No. 23, pp. 5149-5156, 1975.
Ten Cate, “Oral Histology Development, Structure and Function”, Eur J Oral Science, vol. 106, pp. 282-291, 1994.
Tyler-Cross, et al., “Heparin binding domain peptides of antithrombin III: Analysis by isothermal titration calorimetry and circular dichroism spectroscopy”, Protein Science, vol. 3, pp. 620-627, The Protein Society, 1994.
Williams, et al., “Exogenous Matrix Precursors Promote Functional Nerve Regeneration Across a 15-mm Gap Within a Silicone Chamber in the Rat”, The Journal of Comparative Neurology, vol. 264, pp. 284-290, Alan R. Liss, Inc., 1987.
Zucker, et al., “Platelet Factor 4: Production, Structure, and Physiologic and Immunologic Action (43309)”, Exper Biol Med, pp. 693-702, Society for Experimental Biology and Medicine, 1991.
Harding et al., Matrix proteins-the innovative therapy changing the future for hard-to-heal wounds, Full report from the Satellite Symposium at WUWS meeting in Paris, Jul. 2004.

Affiliated with

Also associated with

Rating

Protein formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3974948